Endovia Health Sciences, Inc. EDVA
0.16 USD -0.01 (-7.03%)
At closeNov 12, 2026, 7:50 PM EST
0.17 +0.01 +4.77%
After hours · Nov 12, 7:50 PM ET
0.1609 Day range 0.1699
0.134 52-week range 6.76
- YTD
- -94.16%
- 1 year
- -96.77%
News
benzinga.com 11 Consumer Staples Stocks Moving In Tuesday's After-Market Session Gainers IP Strategy Holdings (NASDAQ:IPST) shares moved upwards by 6.5% to $2.74 during Tuesday's after-market session. The company's market cap stands at $1.5 million. As per the press release, Q2…
benzinga.com Endovia Health Sciences And Lupvindol BioSciences Receives FDA Determination That Proposed Use Of Cannepi For Control Of Pain Associated With Bone Cancer In Dogs Qualifies As 'Minor Use' Center for Veterinary Medicine has determined that the proposed use of CannEpil®, an investigational cannabidiol ("CBD") and tetrahydrocannabinol ("THC") oral solution, for the control of pain…
globenewswire.com Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway FORT LAUDERDALE, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. (“Endovia” or the “Company”) (NYSE American: EDVA), in association with Lupvindol BioSciences (“Lupvindol”),…
benzinga.com Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket Worthington Enterprises surged 15.9% premarket after beating Q1 EPS and sales estimates; Wheeler REIT led gainers, while Jaguar Health and Biomea fell.
benzinga.com Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On Endovia Health Sciences shares jumped 47.83% after hours Tuesday as investors cheered fresh funding for its CannEpil drug program.
globenewswire.com Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways Endovia financing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-derived medicines
benzinga.com Endovia Health Sciences Announces U.S. Drug Enforcement Administration’s Decision To Transfer Marijuana From Schedule I To Schedule II Of Controlled Substances Act; Co. Plans To File Pre-Submission Conference With FDA For CannEpil Endovia Health Sciences, Inc. (NYSE:EDVA) ("Endovia" or the "Company"), an emerging cannabinoid-based health sciences company, today welcomed recent developments in the federal marijuana rescheduling
globenewswire.com Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline Endovia Health Sciences believes the federal government's affirmative support for Schedule III represents a significant evolution in U.S. cannabinoid poli
globenewswire.com Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program FORT LAUDERDALE, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. (NYSE American: EDVA), formerly Splash Beverage Group, Inc. (NYSE American: SBEV) ("Endovia Health" or the…
globenewswire.com Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday FORT LAUDERDALE, Fla., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the “Company”) today announced that its corporate name will change to Endovia Health…